Pascal Billot

USPTO Granted Patents = 8 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Paris, FR (2013 - 2017)
Montreuil, FR (2005 - 2018)

Company Filing History:

Millennium Pharmaceuticals Limited

patents

4. 1 out of 832,843

Other

patents

Years Active: 2005-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10160739 - Crystalline forms of dimethoxy docetaxel and methods for preparing the same (2018-12-25),

2. 9533953 - Method of preparation of crystal forms of 4-(cyclopropylmethoxy)-n-(3,5-dichloro-1-oxidopyridyn-4-yl)-5-methoxypyridine-2-carboxamide and crystal forms thereof (2017-01-03),

3. 8846959 - Crystalline forms of dimethoxy docetaxel and methods for preparing the same (2014-09-30),

4. 8481737 - Solid forms of a chemokine receptor antagonist and methods of use thereof (2013-07-09),

5. 8378128 - Crystalline forms of dimethoxy docetaxel and methods for preparing the same (2013-02-19),

6. 7960549 - Solid forms of a chemokine receptor antagonist and methods of use thereof (2011-06-14),

7. 6982334 - Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid (2006-01-03),

8. 6939970 - Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6 methoxyquinolin-4-propyl]-1-[2-2-thienylthio)ethyl] piperidine-3-carboxylic acid (2005-09-06),

Title: The Innovative Contributions of Pascal Billot

Introduction

Pascal Billot is a notable inventor based in Montreuil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and their crystalline forms. With a total of 8 patents to his name, Billot's work has had a considerable impact on medicinal chemistry.

Latest Patents

Among his latest patents, one focuses on the crystalline forms of dimethoxy docetaxel and methods for preparing the same. This invention relates to anhydrides, solvates, and ethanol hetero-solvates and hydrates of dimethoxy docetaxel, which is crucial for enhancing the efficacy of this compound. Another significant patent involves the method of preparation of crystal forms of 4-(cyclopropylmethoxy)-N-(3,5-dichloro-1-oxidopyridin-4-yl)-5-methoxypyridine-2-carboxamide. This invention outlines a process for preparing various crystal forms designated as Crystal Forms A to I A, which are intended for use as a medicament.

Career Highlights

Throughout his career, Pascal Billot has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma and Sanofi. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulation.

Collaborations

Billot has collaborated with several talented individuals in his field, including Hagit Elmaleh and Alexandre Giuliani. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.

Conclusion

Pascal Billot's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medicinal compounds and their applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.